https://www.moneycontrol.com/news/business/biocon-gets-4-observations-from-usfda-for-andhra-facility-12754205.html
0
0
6/22/24 at 6:29am
Organization
Moneycontrol
Author
PTI
The US Food and Drug Administration (USFDA) concluded a GMP inspection of the company's API facility (Site 5), located at Visakhapatnam, Andhra Pradesh, on June 21, 2024, the company said in a regulatory filing
Create an account
or login to join the discussion